An observational study in Bariatric Surgery Candidate, Obesity, Morbid and Obesity, Adolescent, sponsored by University Hospital, Angers. Recruiting at 1 site in France. Open to participants aged 14 Years to 20 Years. Per ClinicalTrials.gov, last updated 2021-02-23.
Sponsored by University Hospital, Angers · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 66 studies in Obesity, Morbid with a site in France — 13 open to participants now, 15 under way, none of them phase 3. Obesity, Morbid · France.
Among the 66 studies in Obesity, Morbid with a site in France, this one is the 15th largest by planned enrollment of the 23 observational ones that give a count, is one of 3 that started in 2008, is one of 23 observational ones, reaches primary completion later than 0 of the 14 other live ones, and was the 50th registered.
941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.
Browse Obesity, Morbid studies →13 of the 66 studies in Obesity, Morbid with a site in France are open now. Recruiting first, the newest first:
Centre Hospitalier Metropole Savoie · Sites in France
Ages 18+
University Hospital, Toulouse · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
Hospices Civils de Lyon · Sites in France
Ages 18–70
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18–59
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.
This study: 14 Years to 20 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
66 studies; the count open now beside each. This study's row is marked.
First in 1996; this study’s year is marked. 3 started in 2008.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 80 across 311 observational studies indexed under Obesity, Morbid.
Median enrollment 100 across the 42 interventional studies, 170 across the 23 observational. Of the 44 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 66 have an industry lead sponsor. The 10 most frequent:
University Hospital, Angers is the lead sponsor of 481 studies on the registry; 122 are open to participants now.
University Hospital, Angers has 1 study filed under Obesity, Morbid — fewer than ten, so there is no comparison to draw.
6 of the studies in Obesity, Morbid with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02310178University Hospital, MontpellierObesity Cohort : Medical Follow-up of Severe or Morbid Obese Patients Undergoing Bariatric Surgery | 2026-12 |
| NCT02811900IHU StrasbourgAn Evaluation of the Outcomes of Bariatric Surgery - a Cohort Study | 2026-12 |
| NCT03517072University Hospital, LilleDeterminants of the Long-Term Success of Bariatric Surgery | 2027-01 |
| NCT06133413Assistance Publique - Hôpitaux de ParisConnected Scales to Optimize the Maintenance of Weight Lost After Bariatric Surgery and Limit Failures and Reoperations | 2027-02 |
| NCT06119516Assistance Publique - Hôpitaux de ParisTranspulmonary Pressure - Guided Mechanical Ventilation in Morbidly Obese ARDS Patients: a Feasibility Study. | 2027-04-04 |
Add all 6 to your calendar (.ics) → With an account.
Among the 66 studies in Obesity, Morbid with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Obesity affects 3%-4% of the pediatric population and leads to cardiac mortality during adult life. Bariatric surgery is the best treatment for weight loss and preventing obesity associated comorbidities in adults, but its applications and safety are yet to be defined for adolescents.
Since 2008, in France, certain university hospitals have been eligible to perform bariatric surgery for adolescents. It was therfore possible to define its feasibility, potential complications and specific indications.
This led to recommandations published by Health Authorities (HAS) in 2016. However, it seems imperative to continue monitoring these patients in order to improve their management, especially as the use of these surgical techniques becomes increasingly widespread.
The Angers University Hospital is one of the leading hospitals when it comes bariatric surgery for adolescents through its use of gastric bands.
The aim of this protocol is to update data on how effective this surgery is on weight loss and obesity-associated comorbidities, and to monitor medical, psychological and surgical complications associated with this treatment.
Pediatric patients treated in our hospital for morbid obesity (BMI >= 35 Kg.M-2) through different programs with lifestyle and nutritional interventions and, for those who requested it, the possibility of bariatric surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight-loss surgery, with the use of gastric banding
Change of weight parameters at 2 years compared to preoperative baseline
Evaluation of weight loss by weight (Kg), body mass index (BMI, Kg.m-2) and excess body weight (EBWL, %) changes
Time frame: 2 years
Changes of insulin resistance at 2 years
Evaluation of insulin resistance by measure of the HOMA index
Time frame: 2 years
Evaluation of dyslipidemia
Evaluation of lipid profile (cholesterol, triglycerides)
Time frame: 2 years
Evaluation of liver steatosis
Evaluation of liver steatosis and NAFLD on US exam and liver elastometry
Time frame: 2 years
Resolution of comorbidities associated with obesity
Clinical evaluation of the presence/absence of hypertension, sleep apnea, orthopedic disorders and polycystic ovary at two years, compared to Baseline characteristics
Time frame: 2 years
Monitoring of psychiatric profile
Clinical evaluation of the presence/absence of psychiatric disorders such as binge eating, depression, etc...
Time frame: 2 years
Evaluation of quality of life
Evaluation of obesity-related QOL by the use of the PedsQL scale
Time frame: 2 years
Evaluation of cosmetic satisfaction
Evaluation of the patient's level of satisfaction with regards to their surgical scar using the POSAS scale
Time frame: 12 months postoperative
Surgical complications
Monitoring of the occurrence of surgical complications and their severity thanks to the Clavien-Dindo scale at each medical consultation
Time frame: 2 years
Started Jan 2008 (actual). Primary completion is estimated for Oct 2021, 165 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.